U.S. FDA Approves ABRYSVO™, Pfizer's Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older AdultsBusiness Wire • 05/31/23
Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B TrialBusiness Wire • 05/30/23
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend IncomeThe Motley Fool • 05/27/23
The dark side of the weight-loss drug craze: Eating disorders, medication shortages, dangerous knock-offsMarket Watch • 05/26/23
Astellas Highlights Continued Delivery of Strong Cancer Portfolio and Pipeline at 2023 ASCO Annual MeetingPRNewsWire • 05/25/23
Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual MeetingBusiness Wire • 05/25/23